Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed May 5, 2016 · 10-Q · 35 days after period end · 0001193125-16-579939
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | -$33.45M | -$20.57M | -$17.54M | -$12.95M |
| EPS Diluted | -$0.92 | -$0.70 | -$0.74 | -$0.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 5, 2016 · 35 d after period end
